Drug Manufacturers - Major (Healthcare)
Richest
Which company is the richest in the Drug Manufacturers - Major industry?
| # | Symbol | Company | usdBookValue (MRQ) | |
|---|---|---|---|---|
| 1 | 0QLR.LSE | Novartis AG | 85806836500 | 72.0% |
| 2 | 0P6S.LSE | Bayer AG NA | 32348275400 | 27.1% |
| 3 | 532482.BSE | Granules India Limited | 307797415 | 0.3% |
| 4 | 531599.BSE | FDC Limited | 235863700 | 0.2% |
| 5 | 524404.BSE | Marksans Pharma Limited | 207674278 | 0.2% |
| 6 | 506197.BSE | Bliss GVS Pharma Limited | 105183731 | 0.1% |
| 7 | 506820.BSE | AstraZeneca Pharma India Limited | 70054110 | 0.1% |
| 8 | 531633.BSE | Lincoln Pharmaceuticals Limited | 59794454 | 0.1% |
| 9 | 524075.BSE | Albert David Limited | 37077163 | 0.0% |
| 10 | 524212.BSE | Wanbury Limited | -3905116 | 0.0% |
Most Revenue
Which company has the highest revenue in the Drug Manufacturers - Major industry?
| # | Symbol | Company | usdRevenue (TTM) | |
|---|---|---|---|---|
| 1 | 532482.BSE | Granules India Limited | 448025599 | 35.8% |
| 2 | 524404.BSE | Marksans Pharma Limited | 220404541 | 17.6% |
| 3 | 531599.BSE | FDC Limited | 212266274 | 17.0% |
| 4 | 506820.BSE | AstraZeneca Pharma India Limited | 119353430 | 9.5% |
| 5 | 506197.BSE | Bliss GVS Pharma Limited | 89438913 | 7.2% |
| 6 | 531633.BSE | Lincoln Pharmaceuticals Limited | 60726747 | 4.9% |
| 7 | 524212.BSE | Wanbury Limited | 59457981 | 4.8% |
| 8 | 524075.BSE | Albert David Limited | 40646164 | 3.3% |
| 9 | 0QLR.LSE | Novartis AG | 0 | 0.0% |
| 10 | 0P6S.LSE | Bayer AG NA | 0 | 0.0% |
Most Profit
Which company makes the most money in the Drug Manufacturers - Major industry?
| # | Symbol | Company | usdProfit (TTM) | |
|---|---|---|---|---|
| 1 | 0QLR.LSE | Novartis AG | 8821026500 | 66.0% |
| 2 | 0P6S.LSE | Bayer AG NA | 4398170000 | 32.9% |
| 3 | 532482.BSE | Granules India Limited | 49118190 | 0.4% |
| 4 | 524404.BSE | Marksans Pharma Limited | 31690652 | 0.2% |
| 5 | 531599.BSE | FDC Limited | 23090451 | 0.2% |
| 6 | 506820.BSE | AstraZeneca Pharma India Limited | 11815510 | 0.1% |
| 7 | 531633.BSE | Lincoln Pharmaceuticals Limited | 8675017 | 0.1% |
| 8 | 506197.BSE | Bliss GVS Pharma Limited | 8432197 | 0.1% |
| 9 | 524075.BSE | Albert David Limited | 4304813 | 0.0% |
| 10 | 524212.BSE | Wanbury Limited | -1237100 | 0.0% |
Most Efficient
Which company is the most efficient in making money in the Drug Manufacturers - Major industry?
| # | Symbol | Company | Net Profit Margin (TTM) | |
|---|---|---|---|---|
| 1 | 524404.BSE | Marksans Pharma Limited | 0.144 | 18.4% |
| 2 | 531633.BSE | Lincoln Pharmaceuticals Limited | 0.143 | 18.2% |
| 3 | 532482.BSE | Granules India Limited | 0.110 | 14.0% |
| 4 | 531599.BSE | FDC Limited | 0.109 | 13.9% |
| 5 | 524075.BSE | Albert David Limited | 0.106 | 13.5% |
| 6 | 506820.BSE | AstraZeneca Pharma India Limited | 0.099 | 12.6% |
| 7 | 506197.BSE | Bliss GVS Pharma Limited | 0.094 | 12.0% |
| 8 | 0P6S.LSE | Bayer AG NA | 0.000 | 0.0% |
| 9 | 0QLR.LSE | Novartis AG | 0.000 | 0.0% |
| 10 | 524212.BSE | Wanbury Limited | -0.021 | -2.7% |
| Symbol | Debt to Asset Ratio (EOD) | Debt to Asset Ratio (MRQ) | Debt to Asset Ratio (TTM) | Debt to Asset Ratio (YOY) | Debt to Asset Ratio (5Y) | Debt to Asset Ratio (10Y) | Debt to Equity Ratio (EOD) | Debt to Equity Ratio (MRQ) | Debt to Equity Ratio (TTM) | Debt to Equity Ratio (YOY) | Debt to Equity Ratio (5Y) | Debt to Equity Ratio (10Y) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0P6S.LSE | - | 0.739 | 0.739 | 0.739 | 0.696 | 0.660 | - | 2.825 | 2.825 | 2.825 | 2.381 | 2.093 |
| 0QLR.LSE | - | 0.487 | 0.487 | 0.487 | 0.504 | 0.494 | - | 0.948 | 0.948 | 0.948 | 1.028 | 0.989 |
| 506197.BSE | - | 0.236 | 0.236 | 0.262 | 0.264 | 0.364 | - | 0.309 | 0.309 | 0.354 | 0.359 | 0.626 |
| 506820.BSE | - | 0.402 | 0.402 | 0.403 | 0.433 | 0.486 | - | 0.673 | 0.673 | 0.675 | 0.770 | 0.994 |
| 524075.BSE | - | 0.264 | 0.264 | 0.303 | 0.288 | 0.361 | - | 0.359 | 0.359 | 0.436 | 0.406 | 0.605 |
| 524212.BSE | - | 1.108 | 1.108 | 1.066 | 1.392 | 1.443 | - | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| 524404.BSE | - | 0.203 | 0.203 | 0.267 | 0.273 | 0.365 | - | 0.255 | 0.255 | 0.364 | 0.379 | 0.724 |
| 531599.BSE | - | 0.154 | 0.154 | 0.138 | 0.134 | 0.149 | - | 0.182 | 0.182 | 0.160 | 0.155 | 0.176 |
| 531633.BSE | - | 0.145 | 0.145 | 0.190 | 0.196 | 0.334 | - | 0.169 | 0.169 | 0.234 | 0.246 | 0.617 |
| 532482.BSE | - | 0.427 | 0.427 | 0.415 | 0.454 | 0.517 | - | 0.745 | 0.745 | 0.709 | 0.841 | 1.136 |
3rd party ad 
SUPPORTERis ad-free.
SUPPORTERis ad-free.Usd Free Cash Flow (TTM)
Usd Price Per Share (TTM)
Usd Book Value (TTM)
Usd Profit (TTM)
Price Per Share (TTM)
Return On Equity (TTM)
Return On Assets (TTM)
Gross Profit Margin (TTM)
Debt To Equity Ratio (TTM)
Debt To Asset Ratio (TTM)
Quick Ratio (TTM)
Current Ratio (TTM)
Usd Market Cap (TTM)
Market Cap (TTM)
Price To Free Cash Flow Ratio (TTM)
Usd Free Cash Flow To Equity Per Share (TTM)
Free Cash Flow To Equity Per Share (TTM)
Usd Free Cash Flow Per Share (TTM)
Free Cash Flow Per Share (TTM)
Usd Eps (TTM)
Usd Total Gains Per Share (TTM)
Usd Dividend Per Share (TTM)
Usd Book Value Change Per Share (TTM)
Usd Book Value Per Share (TTM)
Usd Revenue (TTM)
Price To Total Gains Ratio (TTM)
Total Gains Per Share (TTM)
Book Value Change Per Share (TTM)
Dividend Per Share (TTM)
Pb Ratio (TTM)
Operating Ratio (TTM)
Net Profit Margin (TTM)
Book Value Per Share (TTM)
Pe Ratio (TTM)
Eps (TTM)
Comments
How you think about this?